Accelerating drug development in pediatric cancer: a novel Phase I study design of venetoclax in relapsed/refractory malignancies

AE Place; K Goldsmith; JP Bourquin; ML Loh; L Gore; DA Morgenstern; Y Sanzgiri; D Hoffman; Y Zhou; JA Ross; B Prine; M Shebley; M McNamee; T Farazi; SY Kim; M Verdugo; L Lash-Fleming; C.M. Zwaan; J Vormoor

doi:10.2217/fon-2018-0121

Accelerating drug development in pediatric cancer: a novel Phase I study design of venetoclax in relapsed/refractory malignancies

AE Place, K Goldsmith, JP Bourquin, ML Loh, L Gore, DA Morgenstern, Y Sanzgiri, D Hoffman, Y Zhou, JA Ross, B Prine, M Shebley, M McNamee, T Farazi, SY Kim, M Verdugo, L Lash-Fleming, C.M. Zwaan, J Vormoor

Pediatrics

Research output: Contribution to journal › Article › Academic › peer-review

55 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2115-2129
Number of pages	15
Journal	Future Oncology
Volume	14
Issue number	21
DOIs	https://doi.org/10.2217/fon-2018-0121
Publication status	Published - 2018

Research programs

EMC MM-02-54-03

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2217/fon-2018-0121

Cite this

Place, AE., Goldsmith, K., Bourquin, JP., Loh, ML., Gore, L., Morgenstern, DA., Sanzgiri, Y., Hoffman, D., Zhou, Y., Ross, JA., Prine, B., Shebley, M., McNamee, M., Farazi, T., Kim, SY., Verdugo, M., Lash-Fleming, L., Zwaan, C. M., & Vormoor, J. (2018). Accelerating drug development in pediatric cancer: a novel Phase I study design of venetoclax in relapsed/refractory malignancies. Future Oncology, 14(21), 2115-2129. https://doi.org/10.2217/fon-2018-0121

@article{5a81a116a7ca4db994e170a3247f262c,

title = "Accelerating drug development in pediatric cancer: a novel Phase I study design of venetoclax in relapsed/refractory malignancies",

author = "AE Place and K Goldsmith and JP Bourquin and ML Loh and L Gore and DA Morgenstern and Y Sanzgiri and D Hoffman and Y Zhou and JA Ross and B Prine and M Shebley and M McNamee and T Farazi and SY Kim and M Verdugo and L Lash-Fleming and C.M. Zwaan and J Vormoor",

year = "2018",

doi = "10.2217/fon-2018-0121",

language = "Undefined/Unknown",

volume = "14",

pages = "2115--2129",

journal = "Future Oncology",

issn = "1479-6694",

publisher = "Taylor & Francis Ltd",

number = "21",

}

Place, AE, Goldsmith, K, Bourquin, JP, Loh, ML, Gore, L, Morgenstern, DA, Sanzgiri, Y, Hoffman, D, Zhou, Y, Ross, JA, Prine, B, Shebley, M, McNamee, M, Farazi, T, Kim, SY, Verdugo, M, Lash-Fleming, L, Zwaan, CM & Vormoor, J 2018, 'Accelerating drug development in pediatric cancer: a novel Phase I study design of venetoclax in relapsed/refractory malignancies', Future Oncology, vol. 14, no. 21, pp. 2115-2129. https://doi.org/10.2217/fon-2018-0121

TY - JOUR

T1 - Accelerating drug development in pediatric cancer: a novel Phase I study design of venetoclax in relapsed/refractory malignancies

AU - Place, AE

AU - Goldsmith, K

AU - Bourquin, JP

AU - Loh, ML

AU - Gore, L

AU - Morgenstern, DA

AU - Sanzgiri, Y

AU - Hoffman, D

AU - Zhou, Y

AU - Ross, JA

AU - Prine, B

AU - Shebley, M

AU - McNamee, M

AU - Farazi, T

AU - Kim, SY

AU - Verdugo, M

AU - Lash-Fleming, L

AU - Zwaan, C.M.

AU - Vormoor, J

PY - 2018

Y1 - 2018

U2 - 10.2217/fon-2018-0121

DO - 10.2217/fon-2018-0121

M3 - Article

C2 - 29595064

SN - 1479-6694

VL - 14

SP - 2115

EP - 2129

JO - Future Oncology

JF - Future Oncology

IS - 21

ER -